The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
In conclusion, a low usPSA predicts minimal BCR risk over the next 2-3 years post-measurement. Patients with low usPSA can benefit from reduced post-surgery PSA monitoring at 2- to 3-year intervals without compromising outcomes. This strategic approach optimizes resource allocation in busy urological outpatient clinics, especially valuable in publicly reimbursed healthcare systems like Finland.
Authors
- Otto Ettala (ORCID: https://orcid.org/0000-0003-1011-4602)
- Mikael Högerman (ORCID: https://orcid.org/0000-0002-4287-9231)
- Heikki Seikkula (ORCID: https://orcid.org/0000-0001-9942-1582)
- Peter J. Boström (ORCID: https://orcid.org/0000-0003-3647-0015)
- Jaakko Hyysalo
Institutions
- University of Turku (FI)
- Turku University Hospital (FI)
- Central Finland Health Care District (FI)
Publication Details
- Journal
- BJUI Compass
- Published
- 2024-09-15
- DOI
- https://doi.org/10.1002/bco2.413
- Citations
- 2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84